Peri-implantitis Market
授權報價
| Single User License | $4,500 USD |
| Multiple User License | $5,500 USD |
| Custom Research License | $8,000 USD |
完整報告名稱與涵蓋範圍
Peri-implantitis Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Non-Surgical, Surgical), By End-User (Dental Clinics, Hospitals), By Region & Competition, 2021-2031F
報告摘要
Market Overview
The Global Peri-implantitis Market is projected to grow substantially from USD 11,024.43 Million in 2025 to USD 17,679.86 Million by 2031, at an 8.19% Compound Annual Growth Rate. Peri-implantitis is a pathological inflammatory condition characterized by soft tissue inflammation and the progressive loss of supporting bone around a dental implant. The market's primary driver is the increasing global volume of dental implant procedures, fueled by an aging population and rising rates of edentulism. As the cumulative number of placed implants increases, the incidence of biological complications like peri-implantitis naturally rises, creating a sustained demand for diagnostic and therapeutic solutions. For example, approximately three million individuals in the United States had dental implants in 2025, according to the American Academy of Implant Dentistry, representing a significant patient pool susceptible to this disease.
Market Driver
The expanding volume of dental implant procedures serves as the main catalyst for the Global Peri-implantitis Market, as the rising count of placed implants directly correlates with a higher incidence of biological complications, thereby increasing the patient pool requiring therapeutic intervention. This trend is underscored by robust financial results from key industry players, signaling continued growth in implant therapy. Concurrently, technological advancements in regenerative and laser therapies are propelling market expansion by providing clinicians with more predictable and efficient protocols for biofilm decontamination and tissue preservation. Innovations such as electrolytic cleaning systems and advanced laser modalities are effectively overcoming limitations of mechanical debridement, thus encouraging higher treatment acceptance. The industry's commitment to standardizing these advanced interventions is further demonstrated by collaborative efforts to establish unified, evidence-based guidelines for managing peri-implant diseases.
Market Challenge
A significant challenge impeding market growth is the unpredictability of clinical outcomes associated with current regenerative treatments for peri-implantitis. The absence of a universally standardized protocol creates considerable uncertainty for dental professionals regarding the long-term success of preservation therapies. This lack of confidence often leads clinicians to opt for implant removal rather than investing in or recommending costly and uncertain preservation procedures, thereby suppressing the adoption of advanced market solutions. This clinical uncertainty, compounded by inconsistent insurance reimbursement for peri-implantitis management, frequently biases decision-making toward explantation as a more predictable and financially prudent alternative. This preference limits the revenue potential for diagnostic and regenerative products, even though clinical data from 2025 indicated peri-implantitis affected roughly 22% of patients with dental implants.
Market Trends
The Global Peri-implantitis Market is undergoing transformation driven by key trends, primarily the integration of Artificial Intelligence and digital imaging for early detection, which shifts clinical focus from reactive treatment to predictive monitoring. Cloud-native platforms and AI-driven diagnostics enable unprecedented precision in identifying initial bone loss and soft tissue anomalies, standardizing care and facilitating timely interventions before significant complications arise. This is supported by the rapid uptake of connected diagnostic ecosystems, as evidenced by Dentsply Sirona's DS Core digital platform exceeding 37,000 unique users. Simultaneously, strategic consolidation through mergers and acquisitions in dental care is establishing robust, vertically integrated networks that streamline the delivery of complex implant therapies. These consolidations aggregate implant systems, digital workflows, and consumables, enhancing operational efficiency, broadening market access, and fostering consistent procedural outcomes, thereby mitigating market fragmentation and solidifying the adoption of standardized implant solutions.
Key Market Players
* Straumann Group
* Dentsply Sirona Inc.
* Zimmer Biomet Holdings, Inc.
* Nobel Biocare Services AG
* Institut Straumann AG
* BioHorizons IPH, Inc.
* Keystone Dental, Inc.
* Thommen Medical AG
* Neoss Limited
* MegaGen Implant Co., Ltd.
Report Scope
In this report, the Global Peri-implantitis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
# Peri-implantitis Market, By Type
* Non-Surgical
* Surgical
# Peri-implantitis Market, By End-User
* Dental Clinics
* Hospitals
# Peri-implantitis Market, By Region
* North America
United States
Canada
Mexico
* Europe
France
United Kingdom
Italy
Germany
Spain
* Asia Pacific
China
India
Japan
Australia
South Korea
* South America
Brazil
Argentina
Colombia
* Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Peri-implantitis Market.
Available Customizations:
Global Peri-implantitis Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
* Detailed analysis and profiling of additional market players (up to five).
目錄 Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Peri-implantitis Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Non-Surgical, Surgical)
5.2.2. By End-User (Dental Clinics, Hospitals)
5.2.3. By Region
5.2.4. By Company (2025)
5.3. Market Map
6. North America Peri-implantitis Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By End-User
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Peri-implantitis Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By End-User
6.3.2. Canada Peri-implantitis Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By End-User
6.3.3. Mexico Peri-implantitis Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By End-User
7. Europe Peri-implantitis Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By End-User
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Peri-implantitis Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By End-User
7.3.2. France Peri-implantitis Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By End-User
7.3.3. United Kingdom Peri-implantitis Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By End-User
7.3.4. Italy Peri-implantitis Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By End-User
7.3.5. Spain Peri-implantitis Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By End-User
8. Asia Pacific Peri-implantitis Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By End-User
8.2.3. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Peri-implantitis Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By End-User
8.3.2. India Peri-implantitis Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By End-User
8.3.3. Japan Peri-implantitis Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By End-User
8.3.4. South Korea Peri-implantitis Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By End-User
8.3.5. Australia Peri-implantitis Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By End-User
9. Middle East & Africa Peri-implantitis Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By End-User
9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Peri-implantitis Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By End-User
9.3.2. UAE Peri-implantitis Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By End-User
9.3.3. South Africa Peri-implantitis Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By End-User
10. South America Peri-implantitis Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By End-User
10.2.3. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Peri-implantitis Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By End-User
10.3.2. Colombia Peri-implantitis Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By End-User
10.3.3. Argentina Peri-implantitis Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By End-User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Peri-implantitis Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Straumann Group
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Dentsply Sirona Inc.
15.3. Zimmer Biomet Holdings, Inc.
15.4. Nobel Biocare Services AG
15.5. Institut Straumann AG
15.6. BioHorizons IPH, Inc.
15.7. Keystone Dental, Inc.
15.8. Thommen Medical AG
15.9. Neoss Limited
15.10. MegaGen Implant Co., Ltd.
16. Strategic Recommendations
17. About Us & Disclaimer
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 TechSci Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們